© 2022 MJH Life Sciences and Endocrinology Network. All rights reserved.
© 2022 MJH Life Sciences™ and Endocrinology Network. All rights reserved.
January 26, 2022
Criteria and types of health care professionals who may screen patients at high risk for cardiovascular disease.
Recommendations for establishing relationships and talking with patients about primary and secondary prevention against cardiovascular events.
October 22, 2021
Muthiah Vaduganathan, MD, MPH, presents a case study for a patient hospitalized with heart failure whose therapy was optimized with an SGLT-2 inhibitor.
A panel of experts provide clinical pearls for primary care providers who manage patients with diabetes and cardiovascular comorbidities.
Robert Busch, MD, provides an overview of the clinical trials supporting improved cardiovascular disease outcomes in patients with and without diabetes.
A panel of experts discuss their experience with multidisciplinary collaboration of care between primary care physicians, cardiologists, endocrinologists, and pharmacists in patients with diabetes and cardiovascular disease.